Your argument misses one crucial issue: what is the probability that a drug at this stage of testing will A) work and B) be safe such that it becomes a valid st

Your argument misses one crucial issue: what is the probability that a drug at this stage of testing will A) work and B) be safe such that it becomes a valid standard of care treatment? If the probability is really low, then less caution will result in cases like these outcompeting the incremental benefit to humanity. I'll give you a hint. The probability is really low.